SERCA2a gene therapy ameliorates pulmonary hypertension in a pig model: comparison of different delivery methods and therapeutic effect

被引：1
|
作者：
Bikou, Olympia [1 ]
Tharakan, Serena [1 ]
Yamada, Kelly [1 ]
Kariya, Taro [1 ]
Aguero, Jaime [1 ]
Fish, Kenneth [1 ]
Ishikawa, Kiyotake [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2020年 / 56卷
关键词：
Pulmonary hypertension;
D O I：
10.1183/13993003.congress-2020.3555
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3555
引用
收藏
页数：2
相关论文
共 28 条
  • [1] Intratracheal Gene Delivery of SERCA2a Ameliorates Chronic Post-Capillary Pulmonary Hypertension A Large Animal Model
    Aguero, Jaume
    Ishikawa, Kiyotake
    Hadri, Lahouaria
    Santos-Gallego, Carlos G.
    Fish, Kenneth M.
    Kohlbrenner, Erik
    Hammoudi, Nadjib
    Kho, Changwon
    Lee, Ahyoung
    Ibanez, Borja
    Garcia-Alvarez, Ana
    Zsebo, Krisztina
    Maron, Bradley A.
    Plataki, Maria
    Fuster, Valentin
    Leopold, Jane A.
    Hajjar, Roger J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (17) : 2032 - 2046
  • [2] Endobronchial Aerosolized AAV1.SERCA2a Gene Therapy in a Pulmonary Hypertension Pig Model: Addressing the Lung Delivery Bottleneck
    Bikou, Olympia
    Tharakan, Serena
    Yamada, Kelly P.
    Kariya, Taro
    Aguero, Jaume
    Gordon, Alexandra
    Mazurek, Renata
    Aikawa, Tadao
    Kohlbrenner, Erik
    Fish, Kenneth M.
    Hajjar, Roger J.
    Ishikawa, Kiyotake
    HUMAN GENE THERAPY, 2022, 33 (9-10) : 550 - 559
  • [3] Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension
    Strauss, Benjamin
    Sassi, Yassine
    Bueno-Beti, Carlos
    Ilkan, Zeki
    Raad, Nour
    Cacheux, Marine
    Bisserier, Malik
    Turnbull, Irene C.
    Kohlbrenner, Erik
    Hajjar, Roger J.
    Hadri, Lahouaria
    Akar, Fadi G.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2019, 127 : 20 - 30
  • [4] Does Electrophysiological Toxicity Limit the Therapeutic Window of Serca2a Gene Therapy?
    Xie, Chaoqin
    Hu, Jun
    Jeong, Dongtak
    Kohlbrenner, Erik
    Najjar, Roger J.
    Akar, Fadi G.
    CIRCULATION, 2014, 130
  • [5] Intratracheal SERCA2a Gene Therapy Interrupts the Formation of Plexiform Lesions and Rescues from Heart Failure in Severe Pulmonary Arterial Hypertension
    Fargnoli, Anthony S.
    Katz, Michael
    Gubara, Sarah
    Bridges, Charles
    Hajjar, Roger J.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S2 - S2
  • [6] Safety and long-term efficacy of AAV1.SERCA2a using nebulizer delivery in a pig model of pulmonary hypertension
    Watanabe, Shin
    Ishikawa, Kiyotake
    Plataki, Maria
    Bikou, Olympia
    Kohlbrenner, Erik
    Aguero, Jaume
    Hadri, Lahouaria
    Zarragoikoetxea, Iratxe
    Fish, Kenneth
    Leopold, Jane A.
    Hajjar, Roger J.
    PULMONARY CIRCULATION, 2018, 8 (04)
  • [7] Airway delivery of AAV1.SERCA2a ameliorates vascular resistance and right ventricular performance in a preclinical model of postcapillary pulmonary hypertension
    Aguero, J.
    Ishikawa, K.
    Kohlbrenner, E.
    Santos-Gallego, C. G.
    Hadri, L.
    Fish, K. M.
    Hammoudi, N.
    Ibanez, B.
    Fuster, V.
    Hajjar, R. J.
    EUROPEAN HEART JOURNAL, 2014, 35 : 761 - 761
  • [8] Comparison of Intracoronary versus Peripheral Vein Delivery of AAV for Gene Therapy in a Pig Model
    Lawn, Richard
    Lawlor, Michael
    Meng, Hui
    Gray, John
    MOLECULAR THERAPY, 2018, 26 (05) : 350 - 350
  • [9] EVALUATION OF THE EFFICIENCY AND SAFETY OF ADENO-ASSOCIATED VIRUS SEROTYPE 9 MEDIATED SERCA2A GENE TRANSFECTION TO MYOCARDIUM BY THREE CARDIAC GENE DELIVERY METHODS IN RATS
    Xu Xiaoxia
    Zhou Qina
    Jiang Tao
    Fan Ping
    Wang Hongli
    Ji Meng
    Yang Shanglei
    Hou Yuemei
    HEART, 2012, 98 : E115 - E116
  • [10] Serca2a Gene Therapy Inhibits Pulmonary Fibrosis By Blocking The Stat3/foxm1 Pathway And Promoting The Snon/ski Axis
    Bisserier, Malik
    CIRCULATION, 2019, 140
123